RebelsFunding has officially announced the results of its much-anticipated December RF-Trading Competition. An impressive 6,578 participants signed up to showcase their trading skills. However, the competition was not without its challenges, as 3,684 contestants were disqualified after violating the rules, leaving a select group of traders to compete for the top positions.
Results of the December RF-Trading Competition by RebelsFunding
Despite the intense competition and challenges, the remaining traders showcased exceptional skills and reached the top. Congratulations to the winners who have demonstrated outstanding performance throughout the month-long competition.
Gopa G. is from Algeria and proved to be the most successful trader, achieving an impressive profit margin of 72.49%. His consistency and strategy were key to his victory, earning him the competition’s top prize.
Santosh M. claimed the second spot with a solid profit of 56.42%. His remarkable performance throughout the competition earned him a place among the best traders.
Riad A. took third place with a noteworthy profit of 47.14%. His trading strategies and execution earned him a spot on the prestigious leaderboard.
The Top 100 traders will receive rewards for their efforts, and the complete leaderboard and stats of the winners are available for viewing at RebelsFunding.
RebelsFunding expressed its gratitude to all participants for their efforts and announced that the next edition of the RF-Trading Competition will be coming soon. For more details and to stay updated on future events, visit RebelsFunding.
About the Firm
RebelsFunding is a proprietary trading firm incorporated on May 5, 2023, under the legal name RIFM, S.R.O. Located in Bratislava, Slovak Republic, RebelsFunding is under the supervision of CEO Marek Soska. It offers traders the opportunity to choose between five account types: a four-step evaluation, a three-step evaluation, a two-step evaluation, a one-step evaluation, and an instant funding program.
Also, don’t forget to read the Review.